Search News

May | 07/05/2020

The MHRA has issued temporary guidance for the management of the Valproate Pregnancy Prevention Programme during coronavirus (COVID-19)

December | 24/12/2019

Supply disruption alert - all strengths of Convulex® (valproic acid) capsules are expected to be out of stock until April 2020 due to a change in pack size

December | 04/12/2019

The high risks associated with exposure to valproate medicines during pregnancy remain a topical, high priority patient safety concern and we would like to highlight recent developments to help improve valproate medicines safety in your pharmacy.

July | 26/07/2019

Superintendent update on the MSO Quarterly report (April-June 2019)

July | 03/07/2019

The MHRA has updated their resources to support compliance with the Pregnancy Prevention Programme in females taking oral retinoid medicines

April | 18/04/2019

Valproate medicines in females: the MHRA has produced updated clinical guidance and an annual risk assessment form to aid compliance with the Pregnancy Prevention Programme

March | 25/03/2019

The MHRA has issued a drug safety update on contraceptive methods and pregnancy testing in women taking teratogenic medicines

February | 25/02/2019

Sanofi has confirmed that there may be supply issues involving all valproate preparations (Epilim and Depakote)

October | 31/10/2018

The shortage of Epilim Chronosphere▼250mg is expected to last until the end of November 2018 – Sanofi has issued advice on alternatives